PUBLISHER: TechNavio | PRODUCT CODE: 2126017
PUBLISHER: TechNavio | PRODUCT CODE: 2126017
Global Sequencing Reagents Market 2026-2030
The global sequencing reagents market is forecasted to grow by USD 4881.0 mn during 2025-2030, accelerating at a CAGR of 12.0% during the forecast period. The report on the global sequencing reagents market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by surging clinical oncology precision medicine applications drive continuous reagent consumption, expanding single cell multiomic research platforms accelerate high volume chemistry utilization, decreasing per genome sequencing costs expand large scale biobank surveillance programs.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 11.6% |
| CAGR | 12% |
| Incremental Value | $4881.0 mn |
Technavio's global sequencing reagents market is segmented as below:
By Technology
- Next-generation sequencing
- Sanger sequencing
- Third generation sequencing
By Application
- Oncology
- Clinical investigation
- Reproductive health
- Agrigenomics and forensics
- Others
By Type
- Sequencing kits
- Library kits
- Template kits
- Control kits
- Others
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the shift toward room temperature stable reagent formulations optimizes distribution logistics as one of the prime reasons driving the global sequencing reagents market growth during the next few years. Also, integration of high fidelity long read chemistry enhances complex genomic resolution and automated high throughput library preparation chemistry enhances diagnostic testing speed will lead to sizable demand in the market.
The report on the global sequencing reagents market covers the following areas:
- Global sequencing reagents market sizing
- Global sequencing reagents market forecast
- Global sequencing reagents market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global sequencing reagents market vendors that include Agilent Technologies Inc., Arbor Biosciences, Bio Rad Laboratories Inc., Element Biosciences Inc., F. Hoffmann La Roche Ltd., GeneMind Biosciences Co. Ltd., GenScript Biotech Corp., Illumina Inc., Lexogen GmbH, MGI Tech Co. Ltd., New England Biolabs Inc., Oxford Nanopore Technologies, Pacific Biosciences Inc., Promega Corp., QIAGEN N.V., Revvity Inc., Singular Genomics System Inc, Takara Bio Inc., Thermo Fisher Scientific Inc., Twist Bioscience Corp.. Also, the global sequencing reagents market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Technology
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Sequencing Reagents Market 2020 - 2024
- Historic Market Size - Data Table on Global Sequencing Reagents Market 2020 - 2024 ($ million)
- 5.2 Technology segment analysis 2020 - 2024
- Historic Market Size - Technology Segment 2020 - 2024 ($ million)
- 5.3 Application segment analysis 2020 - 2024
- Historic Market Size - Application Segment 2020 - 2024 ($ million)
- 5.4 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on global sequencing reagents market
- 6.2 Impact of geopolitical conflicts on global sequencing reagents market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Technology
- 8.1 Market segments
- 8.2 Comparison by Technology
- 8.3 Next-generation sequencing - Market size and forecast 2025-2030
- 8.4 Sanger sequencing - Market size and forecast 2025-2030
- 8.5 Third generation sequencing - Market size and forecast 2025-2030
- 8.6 Market opportunity by Technology
- Market opportunity by Technology ($ million)
9 Market Segmentation by Application
- 9.1 Market segments
- 9.2 Comparison by Application
- 9.3 Oncology - Market size and forecast 2025-2030
- 9.4 Clinical investigation - Market size and forecast 2025-2030
- 9.5 Reproductive health - Market size and forecast 2025-2030
- 9.6 Agrigenomics and forensics - Market size and forecast 2025-2030
- 9.7 Others - Market size and forecast 2025-2030
- 9.8 Market opportunity by Application
- Market opportunity by Application ($ million)
10 Market Segmentation by Type
- 10.1 Market segments
- 10.2 Comparison by Type
- 10.3 Sequencing kits - Market size and forecast 2025-2030
- 10.4 Library kits - Market size and forecast 2025-2030
- 10.5 Template kits - Market size and forecast 2025-2030
- 10.6 Control kits - Market size and forecast 2025-2030
- 10.7 Others - Market size and forecast 2025-2030
- 10.8 Market opportunity by Type
- Market opportunity by Type ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 Japan - Market size and forecast 2025-2030
- 12.5.3 India - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Singapore - Market size and forecast 2025-2030
- 12.5.6 Thailand - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 UAE - Market size and forecast 2025-2030
- 12.6.4 South Africa - Market size and forecast 2025-2030
- 12.6.5 Argentina - Market size and forecast 2025-2030
- 12.6.6 Egypt - Market size and forecast 2025-2030
- 12.6.7 Chile - Market size and forecast 2025-2030
- 12.6.8 Israel - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Surging clinical oncology precision medicine applications drive continuous reagent consumption
- Expanding single cell multiomic research platforms accelerate high volume chemistry utilization
- Decreasing per genome sequencing costs expand large scale biobank surveillance programs
- 13.2 Market challenges
- High chemical synthesis expenses impair multi site population scale sequencing workflows
- Complex cold chain supply infrastructure bottlenecks restrict commercial laboratory operations
- Regulatory compliance uncertainties impede enterprise diagnostics commercialization global market expansion
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Shift toward room temperature stable reagent formulations optimizes distribution logistics
- Integration of high fidelity long read chemistry enhances complex genomic resolution
- Automated high throughput library preparation chemistry enhances diagnostic testing speed
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Agilent Technologies Inc.
- Agilent Technologies Inc. - Overview
- Agilent Technologies Inc. - Business segments
- Agilent Technologies Inc. - Key news
- Agilent Technologies Inc. - Key offerings
- Agilent Technologies Inc. - Segment focus
- SWOT
- 15.5 Bio Rad Laboratories Inc.
- Bio Rad Laboratories Inc. - Overview
- Bio Rad Laboratories Inc. - Business segments
- Bio Rad Laboratories Inc. - Key news
- Bio Rad Laboratories Inc. - Key offerings
- Bio Rad Laboratories Inc. - Segment focus
- SWOT
- 15.6 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- 15.7 GenScript Biotech Corp.
- GenScript Biotech Corp. - Overview
- GenScript Biotech Corp. - Business segments
- GenScript Biotech Corp. - Key offerings
- GenScript Biotech Corp. - Segment focus
- SWOT
- 15.8 Illumina Inc.
- Illumina Inc. - Overview
- Illumina Inc. - Business segments
- Illumina Inc. - Key news
- Illumina Inc. - Key offerings
- Illumina Inc. - Segment focus
- SWOT
- 15.9 New England Biolabs Inc.
- New England Biolabs Inc. - Overview
- New England Biolabs Inc. - Product / Service
- New England Biolabs Inc. - Key offerings
- SWOT
- 15.10 Oxford Nanopore Technologies
- Oxford Nanopore Technologies - Overview
- Oxford Nanopore Technologies - Product / Service
- Oxford Nanopore Technologies - Key offerings
- SWOT
- 15.11 Pacific Biosciences Inc.
- Pacific Biosciences Inc. - Overview
- Pacific Biosciences Inc. - Product / Service
- Pacific Biosciences Inc. - Key offerings
- SWOT
- 15.12 Promega Corp.
- Promega Corp. - Overview
- Promega Corp. - Product / Service
- Promega Corp. - Key offerings
- SWOT
- 15.13 QIAGEN N.V.
- QIAGEN N.V. - Overview
- QIAGEN N.V. - Product / Service
- QIAGEN N.V. - Key offerings
- SWOT
- 15.14 Revvity Inc.
- Revvity Inc. - Overview
- Revvity Inc. - Business segments
- Revvity Inc. - Key offerings
- Revvity Inc. - Segment focus
- SWOT
- 15.15 Singular Genomics System Inc
- Singular Genomics System Inc - Overview
- Singular Genomics System Inc - Key offerings
- SWOT
- 15.16 Takara Bio Inc.
- Takara Bio Inc. - Overview
- Takara Bio Inc. - Product / Service
- Takara Bio Inc. - Key offerings
- SWOT
- 15.17 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
- 15.18 Twist Bioscience Corp.
- Twist Bioscience Corp. - Overview
- Twist Bioscience Corp. - Product / Service
- Twist Bioscience Corp. - Key offerings
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
